Skip to main content
OpenTrials

Clinical trial condition

Recurrent Breast Carcinoma

Explore clinical trials studying Recurrent Breast Carcinoma. Study availability and eligibility vary by location and protocol.

71 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Breast Carcinoma trial results

Completed

Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients

NCT02152943

Conditions
Advanced Malignant Solid Neoplasm, Breast Diseases, Breast Neoplasms, +16 more
Locations
  • M D Anderson Cancer Center Houston, Texas, United States
  • MD Anderson in Katy Houston, Texas, United States
  • MD Anderson League City Nassau Bay, Texas, United States
  • MD Anderson in Sugar Land Sugar Land, Texas, United States
View Trial Details
Completed

Eribulin Mesylate in Treating Patients With Previously Treated Metastatic Breast Cancer

NCT01908101

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Katmai Oncology Group Anchorage, Alaska, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • The University of Arizona Medical Center-University Campus Tucson, Arizona, United States
  • Bozeman Deaconess Hospital Bozeman, Montana, United States
View Trial Details
Completed

Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer

NCT00684983

Conditions
Breast Diseases, Breast Neoplasms, HER2 Positive Breast Carcinoma, +9 more
Locations
  • Providence Hospital Mobile, Alabama, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
  • Mills-Peninsula Medical Center Burlingame, California, United States
View all 390 locations
View Trial Details
Completed

Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive

NCT00390455

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Positive, +11 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Arroyo Grande Community Arroyo Grande, California, United States
  • PCR Oncology Arroyo Grande, California, United States
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
View all 368 locations
View Trial Details
Completed

Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Metastatic Triple-Negative Breast Cancer

NCT01964924

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +11 more
Locations
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
View Trial Details
Completed

Akt Inhibitor MK2206 in Treating Patients With Advanced Breast Cancer

NCT01277757

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +7 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Columbia University/Herbert Irving Cancer Center New York, United States
  • Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details

Related conditions